Dr. Arnold currently serves as CSO at Biocept. In 2010 he founded AEGEA Biotechnologies to acquire, develop, and commercialize, next generation nucleic acid technologies. Dr. Arnold also serves on the board of directors of Asuragen, as well as on the board of AEGEA. Previously, Dr. Arnold held various senior scientific and management positions at Molecular Biosystems (co-founder), Gen-Probe, Genta, Synteni, Incyte Genomics, and Oasis Biosciences (co-founder). Additionally, Dr. Arnold was a faculty member in the UCSD School of Medicine and a member of the UCSD Cancer Center. He is an inventor or co-inventor on 44 issued U.S. patents and more than 140 issued and pending patents worldwide. Dr. Arnold has authored more than 50 scientific publications. He received a B.S. in Chemistry from the University of California at Los Angeles and a Ph.D. in Chemistry/Biochemistry from the University of California at San Diego.
Interrogation of Single Circulating Tumor Cells using Microchannel Enrichment
Tuesday, 27 September 2016 at 14:30
Add to Calendar ▼2016-09-27 14:30:002016-09-27 15:30:00Europe/LondonInterrogation of Single Circulating Tumor Cells using Microchannel EnrichmentNGS, SCA, SMA and Mass Spec: Research to Diagnostics 2016 in San Diego, California, USASan Diego, California, USASELECTBIOenquiries@selectbiosciences.com
Liquid biopsies offer the opportunity to interrogate a number of different target sample types, including CTCs. At Biocept both ctDNA and CTCs are used for identifying medically actionable biomarkers. In this presentation the use of a unique patented microchannel will be high-lighted that enables the capture, enrichment, and analysis of CTCs at the single cell level. This allows for the direct visual analysis of CTCs, and has enabled the clinical validation of an array of biomarkers using FISH and protein analysis methods for HER2, FGFR1, MET, ALK, ROS1, ER, PR, AR, and PDL-1 across a range of cancer types. In addition, CTCs can be isolated from the microchannel and interrogated using other means, including NGS.
Add to Calendar ▼2016-09-26 00:00:002016-09-28 00:00:00Europe/LondonNGS, SCA, SMA and Mass Spec: Research to Diagnostics 2016NGS, SCA, SMA and Mass Spec: Research to Diagnostics 2016 in San Diego, California, USASan Diego, California, USASELECTBIOenquiries@selectbiosciences.com
Add to Calendar ▼2016-09-27 14:30:002016-09-27 15:30:00Europe/LondonInterrogation of Single Circulating Tumor Cells using Microchannel EnrichmentNGS, SCA, SMA and Mass Spec: Research to Diagnostics 2016 in San Diego, California, USASan Diego, California, USASELECTBIOenquiries@selectbiosciences.com
